International Isotopes Inc. (INIS)
OTCMKTS
· Delayed Price · Currency is USD
0.0310
-0.0050 (-11.11%)
Oct 25, 2024, 3:41 PM EDT
International Isotopes Revenue
International Isotopes had revenue of $3.17M in the quarter ending June 30, 2024, with 1.83% growth. This brings the company's revenue in the last twelve months to $12.14M, down -0.02% year-over-year. In the year 2023, International Isotopes had annual revenue of $12.27M with 9.71% growth.
Revenue (ttm)
12.14M
Revenue Growth
-0.02%
P/S Ratio
1.33
Revenue / Employee
303.48K
Employees
40
Market Cap
16.23M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 12.27M | 1.09M | 9.71% |
Dec 31, 2022 | 11.18M | 1.52M | 15.73% |
Dec 31, 2021 | 9.66M | 297.05K | 3.17% |
Dec 31, 2020 | 9.36M | 409.69K | 4.57% |
Dec 31, 2019 | 8.96M | -1.41M | -13.63% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sandoz Group AG | 10.11B |
Telix Pharmaceuticals Limited | 430.80M |
Elekta AB (publ) | 1.69B |
Ryman Healthcare Limited | 411.39M |
Verano Holdings Corp. | 920.97M |
Vireo Growth Inc. | 98.04M |
Medexus Pharmaceuticals Inc. | 108.78M |